Immuno-positron emission tomography with zirconium-89-labeled monoclonal antibodies in oncology

• Päätekijät: Yvonne W.S. Jauw (Tekijä), C. Willemien Menke-van der Houwen van Oordt (Tekijä), Otto S. Hoekstra (Tekijä), N. Harry Hendrikse (Tekijä), Danielle J. Vugts (Tekijä), Josee M. Zijlstra (Tekijä), Marc C. Huisman (Tekijä), Guus A.M.S. van Dongen (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2016-05-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Selection of the right drug for the right patient is a promising approach to increase clinical benefit of targeted therapy with monoclonal antibodies (mAbs). Assessment of in vivo biodistribution and tumor targeting of mAbs to predict toxicity and efficacy is expected to guide individualized treatme...